Coagulopathy and adverse outcomes in hospitalized patients with COVID-19: results from the NOR-Solidarity trial

Several studies have examined parameters of increased thrombogenicity in COVID-19, but studies examining their association with long-term outcome and potential effects of antiviral agents in hospitalized patients with COVID-19 are scarce. To evaluate plasma levels of hemostatic proteins during hospi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Research and practice in thrombosis and haemostasis 2024-01, Vol.8 (1), p.102289, Article 102289
Hauptverfasser:	Ueland, Thor, Michelsen, Annika E., Tveita, Anders Aune, Kåsine, Trine, Dahl, Tuva B., Finbråten, Ane-Kristine, Holten, Aleksander R., Skjønsberg, Ole Henning, Mathiessen, Alexander, Henriksen, Katerina N., Trøseid, Marius, Aaløkken, Trond Mogens, Halvorsen, Bente, Dyrhol-Riise, Anne Ma, Barratt-Due, Andreas, Aukrust, Pål
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 hospitalization Original remdesivir tissue factor pathway inhibitor tissue plasminogen activator
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!